Carl Zeiss secures sale of Acri.Tec

Article

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Acri.Tec, which generated sales revenues of €15.4 million in the 2006 financial year, specializes in innovative implants for ophthalmic surgery. The two companies' products complement each other well and the acquisition will expand Carl Zeiss Meditec's rapidly-growing ophthalmic surgery division.

Recent Videos
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
© 2024 MJH Life Sciences

All rights reserved.